Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study.

Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR.

Blood. 2008 Mar 1;111(5):2563-72. Epub 2007 Dec 21.

2.

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.

Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio M, Cox MC, Cuneo A, Del Poeta G, Dini D, Falzetti D, Fanin R, Gobbi M, Isidori A, Leoni F, Liso V, Malagola M, Martinelli G, Mecucci C, Piccaluga PP, Petti MC, Rondelli R, Russo D, Sessarego M, Specchia G, Testoni N, Torelli G, Mandelli F, Tura S.

Leukemia. 2001 Jun;15(6):903-9. Review.

PMID:
11417475
3.

Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M, Botsonis A, Tsangaris GT.

J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. Review.

PMID:
11902303
4.

Cytogenetics in adult acute lymphocytic leukemia.

Wetzler M.

Hematol Oncol Clin North Am. 2000 Dec;14(6):1237-49. Review.

PMID:
11147221

Supplemental Content

Support Center